市場調查報告書

全球粒子治療市場:成長,趨勢,及預測(2020年∼2025年)

Particle Therapy Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 921917
出版日期 內容資訊 英文 95 Pages
商品交期: 2-3個工作天內
價格
全球粒子治療市場:成長,趨勢,及預測(2020年∼2025年) Particle Therapy Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年01月01日內容資訊: 英文 95 Pages
簡介

全球粒子治療市場在預測期間內預計將以8.6%的年複合成長率成長。而促進該市場成長的主要原因,是粒子治療帶來的優點,及癌症的全球盛行率增加等。還有粒子線治療的創新技術的研究開發的高額投資,預期成為在預測期間內的市場成長要素。

本報告提供全球粒子治療市場的相關調查,市場機會和趨勢,成長及阻礙因素,各類型、系統、癌症的類型、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 粒子線治療所提供的優點
    • 增大的全球性的癌症的負擔
  • 市場阻礙因素
    • 醫療設施的基礎設施的課題
    • 不利的償付方針與限定的保險適用範圍
  • 波特的五力分析

第5章 市場區隔

  • 各類型
    • 質子療法
    • 重離子療法
  • 各系統
    • 多房間系統
    • 單人房系統
  • 癌症的各類型
    • 兒童癌症
    • 前列腺癌
    • 肺癌
    • 乳癌
    • 腦及脊髓癌症
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他

第6章 競爭情形

  • 企業簡介
    • Danfysik A/S
    • Hitachi, Ltd.
    • Ion Beam Applications Sa (IBA)
    • Mevion Medical Systems, Inc.
    • Optivus Proton Therapy, Inc.
    • Protom International, Inc.
    • Provision Healthcare, LLC
    • 住友重機械工業株式會社
    • Varian Medical Systems, Inc.

第7章 市場機會及今後趨勢

目錄
Product Code: 66857

Market Overview

The global Particle Therapy market is expected to witness a CAGR of 8.6% during the forecast period. Certain factors that are driving the market growth include advantages offered by particle therapy and the growing global prevalence of cancer.

The number of people suffering from various cancers has been found to be a major driving factor for this market. Cancer is one of the major life-threatening diseases of our times. According to the WHO, cancer is the second leading cause of death, globally, and was responsible for an estimated 9.6 million deaths in 2018. Globally, about one in six deaths are due to cancer. Approximately 70% of deaths from cancer occur in low and middle-income countries. According to the American Cancer Society, nearly 40,000 people in the United States were diagnosed with head and neck cancer, of which, 12,000 died in the year 2014 alone. Head and neck cancer account for nearly 5-6% of the cancer cases in the United States. It is the 15th most prevalent type of cancer in Europe, with nearly 56,000 cases diagnosed annually. Since particle therapies are used to treat cancer, the growing prevalence of the same is expected to be the major driver of the growth of this market.

Scope of the Report

Particle therapy is a cutting-edge area of external beam radiotherapy. It uses beams of energetic neutrons, protons, or other heavier positive ions for cancer treatment.

Key Market Trends

Particle Therapy in Prostate Cancer is Expected to Hold a Significant Share Over the Forecast Period

Prostate cancer is the second most common type of cancer affecting the male reproductive system. About 80% of men who reach 80 years of age are diagnosed with it. As per the estimates provided by the American Cancer Society, in 2018, the United States witnessed over 164,690 new cases of prostate cancer, with over 29,430 related deaths. About 60% of the total prostate cancer cases diagnosed are among men aged 65 years or older. One in every nine men is expected to be diagnosed with prostate cancer during his lifetime. Thus, considering the aforementioned factors, the concerned segment of the market is expected to witness high growth over the forecast period.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America dominated the global market studied, in 2018. Almost half of all cancer patients in the region, especially in the United States receive cancer treatment. The United States has the largest market for radiotherapy. The market is driven by factors, such as increasing incidences of cancer, replacements of older therapies with newer ones, and the availability of reimbursements for radiation therapy. A few states in the United States have passed laws compelling the personnel performing radiologic procedures to hold licenses. The changes in legislature and availability of reimbursement policies have led to incentivizing the providers to improve patient care and outcomes of treatment while controlling the costs. With large investments being made in R&D of innovative technologies for particle therapy, the market is expected to grow during the forecast period.

Competitive Landscape

The global Particle Therapy market is highly competitive and consists of a number of major players. Companies like Danfysik A/S, Hitachi, Ltd., Ion Beam Applications Sa (IBA), Mevion Medical Systems, Inc., Optivus Proton Therapy, Inc., Protom International, Inc., Provision Healthcare, LLC, Sumitomo Heavy Industries, Ltd., Varian Medical Systems, Inc., among others, hold the substantial market share in the Particle Therapy market.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Advantages Offered By Particle Therapy
    • 4.2.2 Growing Global Burden of Cancer
  • 4.3 Market Restraints
    • 4.3.1 Infrastructural Challenges in Healthcare Facilities
    • 4.3.2 Unfavorable Reimbursement Policies and Limited Insurance Coverage
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Type
    • 5.1.1 Proton Therapy
    • 5.1.2 Heavy Ion Therapy
  • 5.2 By System
    • 5.2.1 Multi-Room Systems
    • 5.2.2 Single-Room Systems
  • 5.3 By Cancer Type
    • 5.3.1 Pediatric Cancer
    • 5.3.2 Prostate Cancer
    • 5.3.3 Lung Cancer
    • 5.3.4 Breast Cancer
    • 5.3.5 Brain and Spinal Cord Cancer
    • 5.3.6 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 US
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 UK
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Rest of World

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Danfysik A/S
    • 6.1.2 Hitachi, Ltd.
    • 6.1.3 Ion Beam Applications Sa (IBA)
    • 6.1.4 Mevion Medical Systems, Inc.
    • 6.1.5 Optivus Proton Therapy, Inc.
    • 6.1.6 Protom International, Inc.
    • 6.1.7 Provision Healthcare, LLC
    • 6.1.8 Sumitomo Heavy Industries, Ltd.
    • 6.1.9 Varian Medical Systems, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS